BioSpace News Archive

Insulet Corporation announced the following appointments to the Company’s Board of Directors, effective January 18.

Acadia Pharmaceuticals Inc. is saddened to announce the passing of its former President, Srdjan Stankovic M.D., M.S.P.H. Serge passed away peacefully on December 29, 2023, following a prolonged illness.

Danimer Scientific, Inc. is pleased to announce that Dr. David Moody and Mr. Richard Altice have been appointed as members of Danimer’s Board of Directors.

Geron Corporation reported that it has granted non-statutory stock options to purchase an aggregate of 895,930 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company.

Bausch Health Companies Inc. and Solta Medical, a global leader in the medical aesthetics market, announced the approval of Thermage® FLX and the TR-4 Return Pad by China’s National Medical Products Administration.

AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies, declared a quarterly cash dividend of $0.41 per share.

Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR) today announced that it and its partner AnGes, Inc. received marketing approval from the Ministry of Health, Labour and Welfare for Zokinvy (lonafarnib), a treatment for Hutchinson-Gilford progeria syndrome (HGPS) and processing deficient progeroid laminopathy (PDPL).

Bowen Acquisition Corp, a special purpose acquisition company, announced the execution of an agreement and plan of merger with Shenzhen Qianzhi BioTechnology Co., Ltd, a biotech company engaged in development, manufacturing and sales of ozonated health and wellness products in China.

Imugene Limited (ASX:IMU), a clinical stage immuno-oncology company, is pleased to announce further details from its poster presentation at the ASCO Gastrointestinal Cancers Symposium (ASCO-GI) currently being conducted in San Francisco.

Thermo Fisher Scientific has received Good Manufacturing Practice approval from the Italian Medicines Agency allowing the company to manufacture RNA-based products at its Monza, Italy site.